Female Sexual Function Index As Sexual Disfunction Predictor On Women Using A Pessary

Authors

  • Setyawan Nurtanio Divison of Reconstructive Urogynaecology, Department Obstetric and Gynaecology, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, West Java, Indonesia
  • Andi Rinaldi Divison of Reconstructive Urogynaecology, Department Obstetric and Gynaecology, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, West Java, Indonesia https://orcid.org/0009-0002-4919-2042
  • R.M. Sonny Sasotya Divison of Reconstructive Urogynaecology, Department Obstetric and Gynaecology, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, West Java, Indonesia https://orcid.org/0000-0003-2702-6895
  • M. Rizkar Arev Sukarsa Divison of Reconstructive Urogynaecology, Department Obstetric and Gynaecology, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, West Java, Indonesia https://orcid.org/0000-0002-9327-0063
  • Eppy Darmadi Achmad Divison of Reconstructive Urogynaecology, Department Obstetric and Gynaecology, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, West Java, Indonesia https://orcid.org/0000-0001-5284-748X

DOI:

https://doi.org/10.25077/aoj.9.2.197-204.2025

Keywords:

Pelvic Organ Prolapse (POP), Female Sexual Function Index (FSFI), pessary, users, sexual dysfunction, menopause

Abstract

Introduction: Pelvic organ prolapse (POP) is the abnormal descent of pelvic organs that can cause various symptoms, including sexual dysfunction, especially in menopausal women. With increasing life expectancy, the prevalence of POP-related female sexual dysfunction is also rising. Sexual discomfort can result from vaginal wall thinning, stiffness, fatigue, and inability to achieve orgasm, affecting overall well-being and quality of life.

Objective: This study aimed to evaluate the improvement in female sexual function using the Indonesian version of the Female Sexual Function Index (FSFI) one week after pessary insertion in both sexually active (SA) and non-sexually active (NSA) women with POP.

Methods: A descriptive before-and-after study was conducted on 20 women aged 50–65 years with POP grades II–IV at Al-Ihsan Hospital, Bandung, between November 2023 and January 2024. All subjects received ring pessary treatment. The FSFI questionnaire was administered before and one week after pessary insertion to assess sexual function.

Results: Among 20 participants (mean age: 57 years), 16 (80%) reported sexual dysfunction before pessary insertion. After one week, 14 women (70%) were categorized as not having sexual dysfunction, while 6 (30%) remained in the dysfunction group. Of the 16 women initially affected, 11 (68%) experienced improved sexual function. The ring pessary proved effective without negatively affecting sexual activity.

Conclusions: Pessary use in women with POP can improve sexual function without adverse effects on sexual intercourse. However, limitations include the small sample size, short follow-up, and use of only one pessary type. Additionally, multiple unmeasured factors, such as biological, cultural, and social factors, can influence outcomes.

References

1. Rogers RG, Pauls RN, Thakar R, et al. An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction. Int Urogynecol J 2018;29:647–666.

2. Handa VL, Cundiff G, Chang HH, Helzlsouer KJ. Female sexual function and pelvic floor disorders. Obstet Gynecol 2008;111:1045–1052.

3. Pangastuti N, Santoso BI, Agustiningsih D, Emilia O. Validation test of Indonesian Female Sexual Function Index (Indonesian FSFI). Bali Med J 2019;8(1):164-168.

4. Farhang F, Bastani P, Khamnian Z, Pourbarghi M, Mallah F. The Comparasion of Sexual Function Before and After Pessary Placement in Women with Pelvic Fllor Disorders. J Evolution Med 2019;8(34):2694-2697.

5. ACOG Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin No. 85: Pelvic organ prolapse. Obstet Gynecol 2007;110:717-29.

6. Ozengin N et al. The Effect of Pelvic Organ Prolapse Type on Sexual Function, Muscle Strength, and Pelvic Floor Syntomps in Women: A Retrospective Study. Turk J Obstet Gynecol 2017;14:121-127.

7. Komesu YM, Rogers RG, Rode MA, et al. Pelvic floor symptom changes in pessary users. Am J Obstet Gynecol 2007;197(6):620.e1-6.

8. Handa VL, Dwyer PL. Sexual function and pelvic floor disorders treatment. Best Pract Res Clin Obstet Gynecol 2011;19:993-1008

9. American Urogynecologic Society, Tulingkas P. Pelvic Organ Prolapse. American Collage of Obstetricians and Gynecologist. 2019;134(5):e126–42.

10. Lazarou G. 2010. Pelvic Organ Prolapse. https://emedicine.medscape.com/ article/276259-overview

11. Iglesia CB, Smithling KR. Pelvic Organ Prolapse. American Family Physician. 2017;96(3):179-85.

12. Pelvic Organ Prolapse: A Guide for Women. (2013). International Urogynecological Association, 24, 1783–1790.

13. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012; 5380: 2163–2196.

14. Walker GJA and Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int Urogynecol J 2011; 22: 127–135.

15. Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 2010;116:1096–100.

16. Prawiroharjo, Sarwono. 2011. Ilmu Penyakit Kandungan. Yayasan bina Pustaka.

17. UNFPA. Status of reproductive morbidities in Nepal, 2006. Kathmandu United Nations Popul Fund, www. advocacynet.org/modules/fck/upload/file/upa/Status of Reproductive Morbidities in Nepal.pdf.

18. Gurung G, Rana A, Amatya A, Bista KD, Joshi AB and Sayami J. Pelvic organ prolapse in rural Nepalese women of reproductive age groups: what makes it so common? Nepal J Obstet Gynaecol 2008; 2: 35–41.

19. Hardianto, G., Prabowo, R.P., Nizomy, I.R. “Correlation between Risk Factors and Pelvic Organ Prolapse in Gynecology Outpatient Clinic, Dr. Soetomo Hospital Surabaya, 2007 – 2011”, Majalah Obstetri & Ginekologi, Vol. 21 No. 2 Mei - Agustus 2013: 61-66.

20. Hardianti, B. Faktor Faktor yang Berhubungan dengan Kejadian Prolapsus Uteri di RSUP Dr Kariadi Semarang. 2015. Fakultas Kedokteran Universitas Diponegoro.

21. Weintraub AY, Glinter H, Braun NM. Narrative Review of The Epidemiology, Diagnosis and Pathophysiology of Pelvic Organ Prolapse. Int Braz J Urol. 2020; 46:5-14.

22. Rantel A, Cert PG. Vaginal Pessaries for Pelvic Organ Prolapse and Their Impact on Sexual Function. Sex Med Rev. 2019;7:597-603.

23. Lee Y, Lim M, Joo J, Park K, Lee S. Seo S. Development and Validation of the Korean Version of the Female Sexual Function Index-6 (FSFI-6K). Yonsei Med J 2014. 55(5),1442-46. doi: https://dx.doi.org/10.3349/ymj.

24. Khan ME, Townsend JW, Pelto PJ. Sexuality, Gender Roles, and Domestic Violence in South Asia. The Population Council, Inc. New York. 2014.

25. Thomas HN, Thurston RC. A Biopsychosocial Approach to Women’s Sexual Function and Dysfunction at Midlife: A Narrative Review. Maturitas. 2016 May ; 87: 49–60. doi: 10.1016/j.maturitas

26. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et. al. The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function. Journal of Sex & Marital Therapy, 2011. 26:2, 191-208 doi: 10.1080/009262300278597.

27. Ryding, E. L., & Blom, C. Validation of the Swedish version of the Female Sexual Function Index (FSFI) in women with hypoactive sexual desire disorder. J Sex Med. 2015. 12, 341–349. doi: 10.1111/jsm.12778.

28. Filocamo, M. T., Serati, M., Li Marzi, V., Costantini, E., Milanesi, M., Pietropaolo, A., and Villari, D. The Female Sexual Function Index (FSFI): Linguistic validation of the Italian version. J Sex Med. 2014. 11, 447–453. doi: 10.1111/ jsm.12389.

29. Takahashi M, Inokuchi T, Watanabe C, Saito T, Kai K. The Female Sexual Function Index (FSFI): Development of a Japanese Version. J Sex Med 2011;8:2246–2254. doi: 10.1111/j.1743-6109.2011.02267.

Downloads

Published

2025-07-25

How to Cite

Setyawan Nurtanio, Andi Rinaldi, R.M. Sonny Sasotya, M. Rizkar Arev Sukarsa, & Eppy Darmadi Achmad. (2025). Female Sexual Function Index As Sexual Disfunction Predictor On Women Using A Pessary. Andalas Obstetrics And Gynecology Journal, 9(2), 197–204. https://doi.org/10.25077/aoj.9.2.197-204.2025

Issue

Section

RESEARCH ARTICLE